172 A Phase 3, Multicenter Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Olanzapine/Samidorphan in Patients with Schizophrenia.
CNS spectrums（2020）
摘要
This study was funded by Alkermes, Inc.
更多查看译文
关键词
olanzapine/samidorphan,schizophrenia,olanzapine/samidorphan,long-term
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要